172 |
Pollock, Carol (7102646018); Moon, Ju-young (7403231326); Ngoc Ha, Le Pham (58866690700); Gojaseni, Pongsathorn (57213457888); Ching, Chen Hua (58867131800); Gomez, Lynn (58865802300); Chan, Tak Mao (58866472300); Wu, Ming-Ju (24482826800); Yeo, See Cheng (58867131900); Nugroho, Pringgodigdo (55987056300); Bhalla, Anil Kumar (58843785900) |
Framework of Guidelines for Management of CKD in Asia |
Kidney International Reports |
0 |
Kolling Institute of Medical Research, University of Sydney, St Leonards, NSW, Australia; Kyung Hee University School of Medicine, Kyung Hee University Hospital at Gangdong, Seoul, South Korea; University of Medicine and Pharmacy, Ho Chi Minh City, Viet Nam; Bhumibol Adulyadej Hospital, Bangkok, Thailand; Hospital Sultanah Bahiyah, Kedah, Alor Setar, Malaysia; Asian Hospital and Medical Center, Metro Manila, Muntinlupa City, Philippines; Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, Hong Kong; Taichung Veterans General Hospital, Taichung City, Taiwan; Tan Tock Seng Hospital Pte Ltd, Singapore; Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Department of Nephrology-Sir Ganga Ram Hospital Marg, Delhi, New Delhi, India |
AstraZeneca Singapore Pte Ltd; Fortrea Scientific Pvt. Ltd.; AstraZeneca |
The authors would like to thank Ms. Prajakta Nachane (M. Pharm) and Dr. Sushma Jayan (PhD), Fortrea Scientific Pvt. Ltd. (formerly Labcorp Scientific Services and Solutions Pvt. Ltd.) for medical writing support that was funded by AstraZeneca in accordance with GPP 2022 guidelines. The manuscript support was funded by AstraZeneca Singapore Pte Ltd (Asia Area). |
Elsevier Inc. |
Q1 |
|
|